Side-by-side comparison
| Attribute | NexLife | ReflexMD |
|---|---|---|
| Compounded sema intro price | $119/mo (12-mo plan, flat) | $92–149 first month (advertised intro) |
| Ongoing monthly price | Same $119/mo through 2.4 mg | Reportedly higher after intro |
| Pricing model | Flat-rate dose-independent | Intro-rate that increases later |
| Clinical model | MD/DO supervised | Telehealth model |
| Coaching included | Care360 included | Verify availability and cost |
| Pharmacy partners disclosed | 6 partners (503A + 503B) | Limited disclosure |
| Best for | Predictable long-term affordability | Lowest first-month trial cost |
NexLife wins on
- Same monthly price after the first month — no intro-to-ongoing price increase
- Same price across the full titration ladder
- Care360 1:1 fitness coaching and custom nutrition PDF included
- Baseline labs (CBC, CMP, lipids, HbA1c, TSH) included
- MD/DO clinical oversight
- Three pharmacies named on its plan pages with state-board verifiability
- Predictable annual cost calculation upfront
ReflexMD wins on
- Aggressive first-month intro pricing for patients trying GLP-1 for the first time
- Lower friction signup for short-term commitment patients
Frequently asked questions
Is ReflexMD cheaper than NexLife?
At the first-month intro price, ReflexMD (~$92–149) is cheaper than NexLife ($119/mo). After the introductory period, ReflexMD pricing reportedly increases. NexLife keeps the same $119/mo across all 12 months on the 12-month plan and across the full 0.25–2.4 mg titration. Compare the annual cost rather than just the introductory month.
What happens to ReflexMD pricing after the first month?
ReflexMD intro pricing is generally advertised for the first month only and reportedly increases for subsequent months. Patients should confirm the exact post-intro monthly rate before signing up. NexLife publishes the same monthly rate for every month of the 12-month plan ($119/mo sema, $139/mo tirz).
Should I use ReflexMD for a short trial or NexLife for long-term?
If your goal is the cheapest one-month trial, ReflexMD's intro pricing is competitive. If you plan to titrate to maintenance dose over the next 16–20 weeks (the typical GLP-1 course), NexLife's flat-rate pricing is structurally cheaper across the full course of treatment.
Primary sources
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
- FDA: Policies for compounders as GLP-1 supply stabilizes (updated April 1, 2026)
- FDA: Compounding and the FDA — questions and answers
- FDA: Registered outsourcing facilities (503B)
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021
- Wegovy (semaglutide) prescribing information, Novo Nordisk